Quality of life profile: from measurement to clinical application

被引:29
作者
Albert, US
Koller, M
Lorenz, W
Kopp, I
Heitmann, C
Stinner, B
Rothmund, M
Schulz, KD
机构
[1] Univ Marburg, Dept Gynecol Gynecol Endocrinol & Oncol, D-35037 Marburg, Germany
[2] Univ Marburg, Dept Visceral Thorac & Vasc Surg, D-35037 Marburg, Germany
[3] Univ Marburg, Inst Theoret Surg, D-35037 Marburg, Germany
关键词
D O I
10.1054/brst.2002.0419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Quality of life (QoL) can be assessed in an accurate, valid and reliable way by means of standardized QoL questionnaires and is an important endpoint in clinical trials today. The aim of this study is to implement quality of life as a diagnostic tool for problem-oriented follow-up care of cancer patients. This is done in the framework of an intervention study in the area of regional health care research using qualitative analysis and the methodological concept of barrier analysis. We developed the diagnostic tool by generating individual, graphic QoL profiles based on patients' responses to the EORTC QLQ-C30 and the corresponding disease-specific modules BR23 for breast cancer and CR38 for rectal cancer. The clinical application is investigated by assessing physicians' responses. The QoL profile is judged as a useful diagnostic tool by all participating physicians. It enables physicians to assess the QoL of the patient and incorporate the knowledge they gain in their daily practice. Especially in breast cancer follow-up care QoL profiles give added value to both patients and doctors. The next implementation steps have to extend the concept of QoL to larger groups of patients and physicians by overcoming the restraining factors as identified in the barrier analysis. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:324 / 334
页数:11
相关论文
共 47 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
[Anonymous], SURG RES
[3]  
[Anonymous], 1963, Feldtheorie in den Sozialwissenschaften
[4]   Cancer undefeated [J].
Bailar, JC ;
Gornik, HL .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (22) :1569-1574
[5]  
Bezjak A, 1997, PSYCHO-ONCOLOGY, V6, P107, DOI 10.1002/(SICI)1099-1611(199706)6:2<107::AID-PON251>3.3.CO
[6]  
2-2
[7]  
BOULDING KE, 1968, MODERN SYSTEMS RES B, pS3
[8]  
Boulton M, 1996, J Eval Clin Pract, V2, P171, DOI 10.1111/j.1365-2753.1996.tb00041.x
[9]  
BUHL A, 1996, SPSS WINDOWS VERSION
[10]   Why don't physicians follow clinical practice guidelines? A framewouk for improvement [J].
Cabana, MD ;
Rand, CS ;
Powe, NR ;
Wu, AW ;
Wilson, MH ;
Abboud, PAC ;
Rubin, HR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (15) :1458-1465